Prescribing Dementia Drugs

AARP Puts the Spotlight on Prescribing of Dementia Drugs

  Seventy percent of elderly dementia patients prescribed dementia drugs are on them long-term despite the lack of evidence that they provide any benefit beyond one year, says a new report released by the AARP Public Policy Institute.  Reducing overuse of dementia drugs could result in substantial savings, estimating $20,000 per patient, for patients insurers.…

Read More

Rhode Island-specific data “at your fingertips”

The Washington-based AARP releases a resource report jampacked with data that will give state and federal policy makers data to make informed policy decisions.  On August 27, 2018, Across the States 2018: Profiles of Long-Term Services and Supports, the 10th edition of Across the States, uthored by AARP’s Public Policy Institute’s Ari Houser, Wendy Fox-Grage, Kathleen…

Read More
West View rehabilitation, West Warwick

By 2030, U.S Demographic Milestone Begins to Lower Caregiver Ratio

Last month, the U.S. Census Bureau announced that the year 2030 marks an important demographic turning point in U.S. history.  According to the Census Bureau’s 2017 National Population Projections, by 2030, all baby boomers will be older than age 65. This will expand the size of the older population so that 1 in every 5…

Read More